Pharmacoeconomic burden in the treatment of psoriatic arthritis: from systematic reviews to real clinical practice studies.
about
Economic impact of biologic utilization patterns in patients with psoriatic arthritisImprovements in productivity at paid work and within the household, and increased participation in daily activities after 24 weeks of certolizumab pegol treatment of patients with psoriatic arthritis: results of a phase 3 double-blind randomised pla
P2860
Pharmacoeconomic burden in the treatment of psoriatic arthritis: from systematic reviews to real clinical practice studies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacoeconomic burden in the ...... eal clinical practice studies.
@en
Pharmacoeconomic burden in the ...... eal clinical practice studies.
@nl
type
label
Pharmacoeconomic burden in the ...... eal clinical practice studies.
@en
Pharmacoeconomic burden in the ...... eal clinical practice studies.
@nl
prefLabel
Pharmacoeconomic burden in the ...... eal clinical practice studies.
@en
Pharmacoeconomic burden in the ...... eal clinical practice studies.
@nl
P2860
P356
P1476
Pharmacoeconomic burden in the ...... real clinical practice studies
@en
P2093
Antonio Spadaro
P2860
P2888
P356
10.1186/1471-2474-15-25
P577
2014-01-20T00:00:00Z
P5875
P6179
1038505800